| P50 | author | Ratna B Ray | Q90724777 |
| P2093 | author name string | Robert Steele | |
| | Ranjit Ray | |
| | Arnab Basu | |
| | Asish K Ghosh | |
| | Adrish Sen | |
| P2860 | cites work | Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses | Q24797827 |
| | Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. | Q27469549 |
| | Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response | Q27469808 |
| | Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | Q27472869 |
| | Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7 | Q27473072 |
| | Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs | Q27473092 |
| | Interference of hepatitis C virus RNA replication by short interfering RNAs | Q27473349 |
| | Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro | Q27473519 |
| | Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region | Q27478292 |
| | Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase | Q27480873 |
| | Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee | Q27485872 |
| | Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA | Q27860484 |
| | Efficient initiation of HCV RNA replication in cell culture | Q27860520 |
| | Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis | Q27860603 |
| | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 |
| | A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 |
| | Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 |
| | How cells respond to interferons | Q27861006 |
| | Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group | Q27861083 |
| | Hepatitis C virus infection is associated with the development of hepatocellular carcinoma | Q28131791 |
| | Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1 | Q28181097 |
| | Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection | Q29620702 |
| | Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome | Q29620780 |
| | Viruses and interferons | Q29620788 |
| | Lack of Protective Immunity Against Reinfection with Hepatitis C Virus | Q29620909 |
| | Cytokines in viral hepatitis | Q33697052 |
| | Hepatitis C virus and hepatocarcinogenesis. | Q33749393 |
| | Current and evolving therapies for hepatitis C. | Q33774667 |
| | Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner | Q33836415 |
| | siRNA-mediated gene silencing in vitro and in vivo. | Q34150604 |
| | RNA interference--2001. | Q34174586 |
| | RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells | Q34178401 |
| | How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. | Q34250843 |
| | RNA interference: listening to the sound of silence | Q34347832 |
| | In vitro models for hepatitis C. | Q34556317 |
| | RNAi targeting an animal virus: news from the front | Q34671263 |
| | Hepatitis viruses: changing patterns of human disease | Q35112094 |
| | Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference | Q39684598 |
| | RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication | Q39685491 |
| | Inhibition of gammaherpesvirus replication by RNA interference | Q39733511 |
| | Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain. | Q39869335 |
| | Modulation of HIV-1 replication by RNA interference | Q40721798 |
| | Short interfering RNA confers intracellular antiviral immunity in human cells | Q40721804 |
| | siRNA-directed inhibition of HIV-1 infection | Q40727988 |
| | Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells | Q40735249 |
| | Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death | Q40871684 |
| | The treatment of chronic viral hepatitis | Q41332870 |
| | Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. | Q42596301 |
| | Hepatitis C virus particle detected by immunoelectron microscopic study | Q43035885 |
| | Treatment of acute hepatitis C with interferon alfa-2b | Q43036093 |
| | Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness | Q43037249 |
| | Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy | Q43038360 |
| | RNA interference in adult mice. | Q43038702 |
| | Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group | Q43040410 |
| | Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice | Q45733379 |
| | Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration | Q71650797 |
| | Hepatocellular carcinoma | Q77355684 |
| P433 | issue | 1-2 | |
| P921 | main subject | RNA interference | Q201993 |
| | Hepatitis C virus | Q708693 |
| P304 | page(s) | 27-35 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Virus Research | Q15749215 |
| P1476 | title | Inhibition of hepatitis C virus protein expression by RNA interference | |
| P478 | volume | 96 | |